ID   ZQNK-29
AC   CVCL_4U93
DR   Wikidata; Q54996112
RX   Patent=CN102876632B;
RX   PubMed=26299072;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201278.
CC   Population: Chinese.
CC   Doubling time: 35.6 hours (PubMed=26299072).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma
DI   ORDO; Orphanet_86879; Extranodal nasal NK/T cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 12
//
RX   Patent=CN102876632B;
RA   Qian L.-J., Gu L.-H., Mou H.-Z., Ling Z.-Q., Feng J.-G., Du L.-B.,
RA   Ling Y.-T., Jiang Z.-M., Sun W.-Y., Kong X.-M., Zhu C.-H., Xu S.-H.,
RA   Mao W.-M.;
RT   "Human NK/T cell line.";
RL   Patent number CN102876632B, 02-Jul-2014.
//
RX   PubMed=26299072; DOI=10.7754/Clin.Lab.2014.140602;
RA   Gu L.-H., Hong L.-L., Ling Z.-Q., Feng J.-G., Zheng Z.-G., Du L.-B.,
RA   Mou H.-Z., Sun W.-Y., Kong X.-M., Ling Y.-T., Jiang Z.-M., Zhu C.-H.,
RA   Mao W.-M., Qian L.-J.;
RT   "Establishment and characterization of a CD20-positive NK/T-cell
RT   lymphoma cell line.";
RL   Clin. Lab. 61:731-739(2015).
//